Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells
The effect of the combination of 10-Hydroxycamptothecin (HCPT) and crizotinib (CRI) on EGFR- and KRAS-mutant lung cancer cells was investigated and the conjugates of the two drugs were synthesised. HCPT combined with CRI synergistically inhibited the cell growth and proliferation of H1975, HCC827, a...
Saved in:
Main Authors: | Zhen Liu (Author), Ye Xu (Author), Lvqian Guo (Author), Xinran Li (Author), Junling Gao (Author), Weiran Xie (Author), Lianbo Zhao (Author), Yuou Teng (Author), Xuejiao Li (Author), Peng Yu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topotecan inhibits metastasis of non-small cell lung cancer by regulating epithelial-mesenchymal transition
by: Zhen Liu, et al.
Published: (2022) -
Crizotinib in treatment of lung cancer
by: Arpita Singh, et al.
Published: (2017) -
Crizotinib in treatment of lung cancer
by: Arpita Singh, et al.
Published: (2017) -
Discovery of highly potent and selective 7-ethyl-10-hydroxycamptothecin-glucose conjugates as potential anti-colorectal cancer agents
by: Chao Yang, et al.
Published: (2022) -
Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy
by: Caifang Gao, et al.
Published: (2019)